183803-69-2

Upstream product

• 142570-81-8 H-(BzlO)Gly-Ala-OBzl 
• 142570-77-2 Boc-Ala-(BzlO)Gly-Ala-OBzl 
• 54837-14-8 2-(benzyloxyamino)acetic acid 
• 17831-01-5 H-Ala-OBzl 
• 15761-38-3 L-N-Boc-Ala 

Downstream Products

• 183803-71-6 (S)-2-{2-[Benzyloxy-((S)-2-{(S)-2-[(S)-2-(2-{benzyloxy-[(S)-2-((S)-2-tert-butoxycarbonylamino-propionylamino)-propionyl]-amino}-acetylamino)-propionylamino]-propionylamino}-propionyl)-amino]-acetylamino}-propionic acid benzyl ester 
• 183803-78-3 (S)-2-{2-[((S)-2-{(S)-2-[(S)-2-(2-{[(S)-2-((S)-2-Amino-propionylamino)-propionyl]-benzyloxy-amino}-acetylamino)-propionylamino]-propionylamino}-propionyl)-benzyloxy-amino]-acetylamino}-propionic acid benzyl ester 
• 183803-76-1 (S)-2-(2-{[(S)-2-((S)-2-Amino-propionylamino)-propionyl]-benzyloxy-amino}-acetylamino)-propionic acid benzyl ester 

Relevant academic research and scientific papers

Iron(III) complex of a trihydroxamate ligand with an Ala-Ala-(HO)Gly-Ala sequence as a model for ferrioxamines. Formation of well-defined peptide loop structure

A dodecapeptide trihydroxamate ligand forms a well-defined chiral complex with iron(III) in which this small linear peptide assumes a unique loop conformation, uncommon to protein structures. The complex exhibits siderophore activity for a test microorganism.